(Q6)Apr 30, 2024 | (FY)Oct 31, 2023 | (Q6)Apr 30, 2023 | (FY)Oct 31, 2022 | (Q6)Apr 30, 2022 | (FY)Oct 31, 2021 | (Q6)Apr 30, 2021 | (FY)Oct 31, 2020 | (Q6)Apr 30, 2020 | (FY)Oct 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -129.58%-3.31M | 2,410.09%27.11M | 48.78%11.2M | -93.89%1.08M | -61.64%7.53M | 61.45%17.68M | 39.38%19.62M | -41.60%10.95M | 47.50%14.08M | -18.51%18.75M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | -35.62%-1.31M | -58.27%-2.24M | -73.51%-963K | -266.32%-1.41M | -249.06%-555K | 17.70%-386K | 40.89%-159K | -31.74%-469K | -47.80%-269K | 57.52%-356K |
Attributable subsidiary (profit) loss | -122.95%-14K | -52.98%-231K | 369.23%61K | -39.81%-151K | 425.00%13K | -83.05%-108K | 91.84%-4K | 39.18%-59K | 0.00%-49K | -61.67%-97K |
Impairment and provisions: | ---- | 546.61%3.15M | ---- | -62.82%487K | ---- | 120.86%1.31M | ---- | -1,731.43%-6.28M | -2,303.82%-6.92M | --385K |
-Impairment of trade receivables (reversal) | ---- | 353.89%3.68M | ---- | -210.76%-1.45M | ---- | 105.01%1.31M | ---- | 65.97%639K | ---- | --385K |
-Other impairments and provisions | ---- | -127.61%-535K | ---- | --1.94M | ---- | ---- | ---- | ---6.92M | -2,303.82%-6.92M | ---- |
Revaluation surplus: | ---- | ---- | ---- | --22K | ---- | ---- | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | ---- | ---- | --22K | ---- | ---- | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | ---224K | -356.76%-2.2M | ---- | -11,925.00%-481K | 24,700.00%246K | 99.20%-4K | 99.70%-1K | -27.34%-503K | -76.04%-338K | 65.77%-395K |
-Loss (gain) on sale of property, machinery and equipment | ---224K | -202.20%-2.2M | ---- | -18,075.00%-727K | ---- | 97.55%-4K | -150.00%-1K | 24.19%-163K | 128.57%2K | -216.18%-215K |
-Loss (gain) from selling other assets | ---- | ---- | ---- | --246K | --246K | ---- | ---- | -88.89%-340K | -83.78%-340K | 82.56%-180K |
Depreciation and amortization: | -45.03%1.01M | -17.39%3.39M | -4.33%1.83M | -10.03%4.1M | -3.67%1.92M | 15.87%4.56M | 8.75%1.99M | -1.75%3.93M | -14.26%1.83M | 60.38%4M |
Financial expense | -81.82%2K | 50.00%3K | -90.83%11K | -97.89%2K | -26.38%120K | -64.55%95K | -66.80%163K | -74.21%268K | 23.68%491K | 1,661.02%1.04M |
Special items | ---- | -94.59%2K | ---- | 146.67%37K | --23K | -87.50%15K | ---- | 140.00%120K | ---- | --50K |
Operating profit before the change of operating capital | -131.70%-3.85M | 687.18%28.98M | 30.69%12.14M | -84.10%3.68M | -57.01%9.29M | 190.99%23.15M | 144.98%21.61M | -65.96%7.96M | -26.28%8.82M | -0.56%23.37M |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | 218.81%56.72M | -398.23%-94.06M | -556.49%-47.74M | 177.94%31.54M | 65.56%-7.27M | -217.97%-40.47M | -151.03%-21.11M | 244.66%34.3M | 703.25%41.38M | 20.40%-23.71M |
Accounts payable increase (decrease) | -297.19%-52.85M | 161.59%70.03M | 66.63%26.8M | 56.45%26.77M | 99.26%16.09M | 141.26%17.11M | 114.48%8.07M | -169.14%-41.48M | -531.70%-55.75M | 800.50%59.99M |
Special items for working capital changes | ---- | -551.74%-13.12M | ---- | -81.05%2.91M | 366.43%42.67M | 244.28%15.33M | -41.67%9.15M | 71.20%-10.63M | 203.60%15.68M | -23.78%-36.9M |
Cash from business operations | -532.09%-5.24M | -112.59%-8.17M | -101.36%-829K | 328.94%64.9M | 243.05%60.77M | 253.74%15.13M | 74.89%17.72M | -143.25%-9.84M | 251.46%10.13M | 177.31%22.75M |
Other taxs | -192.16%-4.99M | -155.25%-4.57M | -70.39%-1.71M | 71.83%-1.79M | 60.42%-1M | 26.03%-6.36M | -35.44%-2.53M | -117.00%-8.59M | 1.21%-1.87M | 62.68%-3.96M |
Net cash from operations | -303.19%-10.23M | -120.19%-12.74M | -104.25%-2.54M | 619.18%63.11M | 293.71%59.77M | 147.61%8.78M | 83.83%15.18M | -198.07%-18.43M | 735.83%8.26M | 146.94%18.8M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 35.62%1.31M | 58.27%2.24M | 73.51%963K | 266.32%1.41M | 249.06%555K | -17.70%386K | 11.97%159K | 31.74%469K | 153.57%142K | -36.20%356K |
Dividend received - investment | 0.00%47K | 0.00%47K | 0.00%47K | 0.00%47K | 0.00%47K | -2.08%47K | --47K | --48K | ---- | ---- |
Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.69%7K | ---- | -65.13%2.29M |
Decrease in deposits (increase) | 98.28%-187K | -243.38%-3.16M | -3,649.31%-10.87M | 166.43%2.2M | 89.01%-290K | -309.12%-3.32M | ---2.64M | -188.15%-811K | ---- | 192.00%920K |
Sale of fixed assets | --224K | 113.11%2.31M | ---- | 2,827.03%1.08M | ---- | -91.53%37K | -95.24%1K | 83.61%437K | -93.50%21K | 226.03%238K |
Purchase of fixed assets | -3,428.57%-2.22M | -453.90%-6.04M | 90.03%-63K | 66.05%-1.09M | 72.99%-632K | 13.25%-3.21M | -40.37%-2.34M | -73.94%-3.71M | -11.28%-1.67M | -50.00%-2.13M |
Recovery of cash from investments | ---- | ---- | ---- | --2M | --2M | ---- | ---- | 167.18%1.05M | 168.54%1.05M | -85.06%393K |
Cash on investment | 94.80%-38K | ---- | 55.07%-731K | ---1.63M | ---1.63M | ---- | ---- | ---- | ---- | ---- |
Other items in the investment business | ---- | --28K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from investment operations | 91.83%-871K | -213.64%-4.58M | -20,207.55%-10.66M | 166.51%4.03M | 101.11%53K | -142.00%-6.06M | -951.10%-4.77M | -221.31%-2.51M | -254.69%-454K | -72.44%2.07M |
Net cash before financing | 15.85%-11.1M | -125.80%-17.32M | -122.06%-13.2M | 2,374.75%67.14M | 474.71%59.82M | 112.96%2.71M | 33.38%10.41M | -200.37%-20.94M | 807.44%7.8M | 164.09%20.86M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 158.72%7.79M |
Refund | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -7,056.67%-12.88M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --70.33M | --28.11M | ---- |
Interest paid - financing | ---- | -50.00%-3K | ---- | 97.89%-2K | ---- | 64.55%-95K | ---- | 80.66%-268K | -23.68%-491K | -2,848.94%-1.39M |
Dividends paid - financing | ---- | -91.56%-22.93M | ---- | ---11.97M | ---- | ---- | ---- | ---- | ---- | 81.67%-2.2M |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -551.36%-13.67M | ---14.28M | ---2.1M |
Other items of the financing business | 81.82%-2K | ---- | 90.83%-11K | ---- | 26.38%-120K | ---- | ---163K | ---- | ---- | ---- |
Net cash from financing operations | 81.82%-2K | -80.29%-23.04M | 98.72%-11K | -238.40%-12.78M | 52.91%-858K | -107.14%-3.78M | -115.37%-1.82M | 504.07%52.91M | 454.09%11.86M | -34.00%-13.09M |
Effect of rate | 98.07%-8K | -103.67%-31K | -253.90%-414K | 293.36%845K | 142.36%269K | 79.58%-437K | ---635K | ---2.14M | ---- | ---- |
Net Cash | 15.90%-11.11M | -174.24%-40.36M | -122.40%-13.21M | 5,214.02%54.36M | 586.67%58.96M | -103.32%-1.06M | -56.32%8.59M | 311.69%31.97M | 890.15%19.66M | 118.35%7.77M |
Begining period cash | -41.28%57.45M | 129.50%97.84M | 129.50%97.84M | -3.40%42.63M | -3.40%42.63M | 208.62%44.13M | 208.62%44.13M | 118.86%14.3M | 118.86%14.3M | -86.63%6.53M |
Cash at the end | -44.98%46.33M | -41.28%57.45M | -17.32%84.22M | 129.50%97.84M | 95.58%101.87M | -3.40%42.63M | 53.37%52.08M | 208.62%44.13M | 739.32%33.96M | 118.86%14.3M |
Cash balance analysis | ||||||||||
Currency Unit | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Nobunaga Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Nobunaga Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Nobunaga Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Nobunaga Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Deloitte & Touche Tohmatsu Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data